Although these data indicate that VLA-4 and integrins protect CLL cells from apoptosis, one study reported that recombinant VCAM-1 and BM MSCs did not inhibit spontaneous apoptosis in both CD49d-positive and -negative isolated CLL cells [182], failing to demonstrate these effects. This evidence concerns the gene VCAM1 and B-cell chronic lymphocytic leukemia.